Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2012

Open Access 01-12-2012 | Research

Establishing a network of specialist Porphyria centres - effects on diagnostic activities and services

Authors: Mette C Tollånes, Aasne K Aarsand, Jørild Haugen Villanger, Egil Støle, Jean-Charles Deybach, Joanne Marsden, Jordi To-Figueras, Sverre Sandberg, On behalf of the European Porphyria Network (EPNET)

Published in: Orphanet Journal of Rare Diseases | Issue 1/2012

Login to get access

Abstract

Background

The porphyrias are a heterogeneous group of rare metabolic diseases. The full spectrum of porphyria diagnostics is usually performed by specialized porphyria laboratories or centres. The European Porphyria Initiative (EPI), a collaborative network of porphyria centres formed in 2001, evolved in 2007 into the European Porphyria Network (EPNET), where participating centres are required to adhere to agreed quality criteria. The aim of this study was to examine the state and distribution of porphyria diagnostic services in 2009 and to explore potential effects of increased international collaboration in the field of these rare diseases in the period 2006–2009.

Methods

Data on laboratory, diagnostic and clinical activities and services reported to EPI/EPNET in yearly activity reports during 2006 through 2009 were compared between reporting centres, and possible time trends explored.

Results

Thirty-five porphyria centres from 22 countries, five of which were non-European associate EPNET members, filed one or more activity reports to EPI/EPNET during the study period. Large variations between centres were observed in the analytical repertoire offered, numbers of analyses performed and type and number of staff engaged. The proportion of centres fulfilling the minimum criteria set by EPNET to be classified as a specialist porphyria centre increased from 80% to 94% during the study period.

Conclusions

Porphyria services are unevenly distributed, and some areas are probably still lacking in specialized porphyria services altogether. However, improvements in the quality of diagnostic services provided by porphyria centres participating in EPI/EPNET were observed during 2006 through 2009.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Pampolos T: Inherited Metabolic Rare Disease. Rare Diseases Epidemiology 1st edition. Edited by: Posada de la Paz M, Groft SC. Netherlands: Springer; 2010:397-431.CrossRef Pampolos T: Inherited Metabolic Rare Disease. Rare Diseases Epidemiology 1st edition. Edited by: Posada de la Paz M, Groft SC. Netherlands: Springer; 2010:397-431.CrossRef
3.
go back to reference Deybach JC, Badminton M, Puy H, Sandberg S, Frank J, Harper P, Martasek P, Minder E, Parker S, Thunell S, Elder G: European porphyria initiative (EPI): a platform to develop a common approach to the management of porphyrias and to promote research in the field. Physiol Res. 2006, 55 (Suppl 2): S67-S73.PubMed Deybach JC, Badminton M, Puy H, Sandberg S, Frank J, Harper P, Martasek P, Minder E, Parker S, Thunell S, Elder G: European porphyria initiative (EPI): a platform to develop a common approach to the management of porphyrias and to promote research in the field. Physiol Res. 2006, 55 (Suppl 2): S67-S73.PubMed
5.
go back to reference Deybach JC BM, Elder G, Parker S, Sandberg S: European Porphyria Network - Providing better healthcare for patients and their families Final report. 2010 Deybach JC BM, Elder G, Parker S, Sandberg S: European Porphyria Network - Providing better healthcare for patients and their families Final report. 2010
6.
go back to reference Whatley SD, Mason NG, Woolf JR, Newcombe RG, Elder GH, Badminton MN: Diagnostic strategies for autosomal dominant acute porphyrias: retrospective analysis of 467 unrelated patients referred for mutational analysis of the HMBS, CPOX, or PPOX gene. Clin Chem. 2009, 55: 1406-1414. 10.1373/clinchem.2008.122564.CrossRefPubMed Whatley SD, Mason NG, Woolf JR, Newcombe RG, Elder GH, Badminton MN: Diagnostic strategies for autosomal dominant acute porphyrias: retrospective analysis of 467 unrelated patients referred for mutational analysis of the HMBS, CPOX, or PPOX gene. Clin Chem. 2009, 55: 1406-1414. 10.1373/clinchem.2008.122564.CrossRefPubMed
7.
go back to reference Aarsand AK, Villanger JH, Stole E, Deybach JC, Marsden J, To-Figueras J, Badminton M, Elder GH, Sandberg S: European Specialist Porphyria Laboratories: Diagnostic Strategies, Analytical Quality, Clinical Interpretation, and Reporting as Assessed by an External Quality Assurance Program. Clin Chem. 2011, 57: 1514-1523. 10.1373/clinchem.2011.170357.CrossRefPubMed Aarsand AK, Villanger JH, Stole E, Deybach JC, Marsden J, To-Figueras J, Badminton M, Elder GH, Sandberg S: European Specialist Porphyria Laboratories: Diagnostic Strategies, Analytical Quality, Clinical Interpretation, and Reporting as Assessed by an External Quality Assurance Program. Clin Chem. 2011, 57: 1514-1523. 10.1373/clinchem.2011.170357.CrossRefPubMed
9.
go back to reference Whatley SD, Ducamp S, Gouya L, Grandchamp B, Beaumont C, Badminton MN, Elder GH, Holme SA, Anstey AV, Parker M, Corrigall AV, Meissner PN, Hift RJ, Marsden JT, Ma Y, Mieli-Vergani G, Deybach JC, Puy H: C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload. Am J Hum Genet. 2008, 83: 408-414. 10.1016/j.ajhg.2008.08.003.PubMedCentralCrossRefPubMed Whatley SD, Ducamp S, Gouya L, Grandchamp B, Beaumont C, Badminton MN, Elder GH, Holme SA, Anstey AV, Parker M, Corrigall AV, Meissner PN, Hift RJ, Marsden JT, Ma Y, Mieli-Vergani G, Deybach JC, Puy H: C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload. Am J Hum Genet. 2008, 83: 408-414. 10.1016/j.ajhg.2008.08.003.PubMedCentralCrossRefPubMed
10.
go back to reference Bylesjo I, Wikberg A, Andersson C: Clinical aspects of acute intermittent porphyria in northern Sweden: a population-based study. Scand J Clin Lab Invest. 2009, 69: 612-618. 10.1080/00365510902935979.CrossRefPubMed Bylesjo I, Wikberg A, Andersson C: Clinical aspects of acute intermittent porphyria in northern Sweden: a population-based study. Scand J Clin Lab Invest. 2009, 69: 612-618. 10.1080/00365510902935979.CrossRefPubMed
11.
go back to reference Tjensvoll K, Bruland O, Floderus Y, Skadberg O, Sandberg S, Apold J: Haplotype analysis of Norwegian and Swedish patients with acute intermittent porphyria (AIP): Extreme haplotype heterogeneity for the mutation R116W. Dis Markers. 2003, 19: 41-46.PubMedCentralCrossRefPubMed Tjensvoll K, Bruland O, Floderus Y, Skadberg O, Sandberg S, Apold J: Haplotype analysis of Norwegian and Swedish patients with acute intermittent porphyria (AIP): Extreme haplotype heterogeneity for the mutation R116W. Dis Markers. 2003, 19: 41-46.PubMedCentralCrossRefPubMed
12.
go back to reference Aarsand AK, Boman H, Sandberg S: Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies. Clin Chem. 2009, 55: 795-803. 10.1373/clinchem.2008.117432.CrossRefPubMed Aarsand AK, Boman H, Sandberg S: Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies. Clin Chem. 2009, 55: 795-803. 10.1373/clinchem.2008.117432.CrossRefPubMed
13.
go back to reference Meissner PN, Dailey TA, Hift RJ, Ziman M, Corrigall AV, Roberts AG, Meissner DM, Kirsch RE, Dailey HA: A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria. Nat Genet. 1996, 13: 95-97. 10.1038/ng0596-95.CrossRefPubMed Meissner PN, Dailey TA, Hift RJ, Ziman M, Corrigall AV, Roberts AG, Meissner DM, Kirsch RE, Dailey HA: A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria. Nat Genet. 1996, 13: 95-97. 10.1038/ng0596-95.CrossRefPubMed
14.
go back to reference Elder G, Harper P, Badminton M, Sandberg S, Deybach JC: The Incidence of inherited porphyrias in Europe. J Inherit Metab Dis. 2012, [Epub ahead of print] Elder G, Harper P, Badminton M, Sandberg S, Deybach JC: The Incidence of inherited porphyrias in Europe. J Inherit Metab Dis. 2012, [Epub ahead of print]
Metadata
Title
Establishing a network of specialist Porphyria centres - effects on diagnostic activities and services
Authors
Mette C Tollånes
Aasne K Aarsand
Jørild Haugen Villanger
Egil Støle
Jean-Charles Deybach
Joanne Marsden
Jordi To-Figueras
Sverre Sandberg
On behalf of the European Porphyria Network (EPNET)
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2012
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/1750-1172-7-93

Other articles of this Issue 1/2012

Orphanet Journal of Rare Diseases 1/2012 Go to the issue